A meta-analysis of cardiopulmonary resuscitation with and without the administration of thrombolytic agents

Resuscitation

Volumn 70, Issue 1, 2006, Pages 31-36

  Li, Xin ^a   Fu, Qing ling ^b   Jing, Xiao li ^a   Li, Yu jie ^a   Zhan, Hong ^a   Ma, Zhong fu ^a   Liao, Xiao xing ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cardiopulmonary resuscitation (CPR); Drug therapy; Thrombolysis

Indexed keywords

FIBRINOLYTIC AGENT;

ARTICLE; BLEEDING; CIRCULATION; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; EVALUATION; FIBRINOLYTIC THERAPY; HEART ARREST; HOSPITAL DISCHARGE; HUMAN; MEDLINE; META ANALYSIS; NEUROLOGIC DISEASE; PRIORITY JOURNAL; RESUSCITATION; SURVIVAL RATE; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

CARDIOPULMONARY RESUSCITATION; FIBRINOLYTIC AGENTS; HEART ARREST; HUMANS; PROGNOSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33745163997     PISSN: 03009572     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resuscitation.2005.11.016     Document Type: Article

References (13)

1. Rosenthal R. The file drawer problem and tolerance for null results. Psychol Bull 86 (1979) 638-641
2. Janata K., Holzer M., Kurkciyan I., et al. Major bleeding complications in cardiopulmonary resuscitation: the place of thrombolytic therapy in cardiac arrest due to massive pulmonary embolism. Resuscitation 57 (2003) 49-55
3. Kurkciyan I., Meron G., Sterz F., et al. Major bleeding complications after cardiopulmonary resuscitation: impact of thrombolytic treatment. J Intern Med 253 (2003) 128-135
4. Schreiber W., Gabriel D., Sterz F., et al. Thrombolytic therapy after cardiac arrest and its effect on neurological outcome. Resuscitation 52 (2002) 63-69
5. Lederer W., Lichtenberger C., Pechlaner C., et al. Recombinant tissue plasminogen activator during cardiopulmonary resuscitation in 108 patients with out-of-hospital cardiac arrest. Resuscitation 5 (2001) 71-76
6. Ruiz-Bailen M., Aguayo de Hoyos E., Serrano-Corcoles M.C., et al. Efficacy of thrombolysis in patients with acute myocardial infarction requiring cardiopulmonary resuscitation. Intensive Care Med 27 6 (2001) 1050-1057
7. Bottiger B.W., Bode C., Kern S., et al. Efficacy and safety of thrombolytic therapy after initially unsuccessful cardiopulmonary resuscitation: a prospective clinical trial. Lancet 357 (2001) 1583-1585
8. Bulut S., Aengevaeren W.R., Luijten H.J., and Verheugt F.W. Successful out-of-hospital cardiopulmonary resuscitation: what is the optimal in-hospital treatment strategy?. Resuscitation 47 (2000) 155-161
9. Kurkciyan I., Meron G., Sterz F., et al. Pulmonary embolism as a cause of cardiac arrest: presentation and outcome. Arch Intern Med 160 (2000) 1529-1535
10. van Campen L.C., van Leeuwen G.R., and Verheugt F.W. Safety and efficacy of thrombolysis for acute myocardial infarction in patients with prolonged out-of-hospital cardiopulmonary resuscitation. Am J Cardiol 73 (1994) 953-955
11. Wenzel V., Krismer A.C., Arntz H.R., et al. A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation. N Engl J Med 350 2 (2004) 105-113
12. Newman D.H., Greenwald L., and Calleway C. Cardiac arrest and the role of thrombolytic agents. Ann Emerg Med 35 5 (2000) 472-480
13. Fischer M., Bottiger B.W., Popov-Cenic S., and Hossmann K.A. Thrombolysis using plasminogen activator and heparin reduces cerebral no-reflow after resuscitation from cardiac arrest: an experimental study in the cat. Intensive Care Med 22 11 (1996) 1214-1223